Teladoc Health Inc (NYSE:TDOC) insider Lewis Levy sold 1,285 shares of the firm’s stock in a transaction that occurred on Friday, February 15th. The stock was sold at an average price of $67.21, for a total transaction of $86,364.85. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
Lewis Levy also recently made the following trade(s):
- On Tuesday, January 15th, Lewis Levy sold 1,284 shares of Teladoc Health stock. The stock was sold at an average price of $57.00, for a total transaction of $73,188.00.
- On Monday, December 17th, Lewis Levy sold 640 shares of Teladoc Health stock. The stock was sold at an average price of $50.00, for a total transaction of $32,000.00.
Shares of NYSE TDOC traded down $0.49 during trading hours on Wednesday, hitting $69.50. 922,908 shares of the stock were exchanged, compared to its average volume of 1,178,547. The company has a current ratio of 8.99, a quick ratio of 8.99 and a debt-to-equity ratio of 0.40. The firm has a market capitalization of $4.92 billion, a price-to-earnings ratio of -42.12 and a beta of 1.47. Teladoc Health Inc has a 1-year low of $36.60 and a 1-year high of $89.05.
TDOC has been the topic of several recent research reports. Berenberg Bank initiated coverage on shares of Teladoc Health in a report on Thursday, January 31st. They set a “buy” rating and a $80.00 target price on the stock. Zacks Investment Research raised shares of Teladoc Health from a “hold” rating to a “buy” rating and set a $54.00 target price on the stock in a report on Saturday, January 5th. Jefferies Financial Group set a $95.00 price target on shares of Teladoc Health and gave the stock a “buy” rating in a research report on Friday, November 2nd. Chardan Capital increased their price target on shares of Teladoc Health from $98.00 to $100.00 and gave the stock a “buy” rating in a research report on Friday, November 2nd. Finally, Cantor Fitzgerald reiterated a “hold” rating and set a $83.00 price target on shares of Teladoc Health in a research report on Monday, January 7th. Four investment analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the stock. Teladoc Health presently has a consensus rating of “Buy” and a consensus target price of $83.84.
About Teladoc Health
Teladoc Health, Inc provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.
Recommended Story: Futures Contract
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.